The/V-methyl-D-aspartate (NMDA) receptor complex plays a central role in the modulation of neuronal information in the central nervous system. This study was designed to examine the pharmacokinetics of the NMDA antagonist 3-(2-carboxypiperazin-4-yl)propyl-1 -phosphonic acid (CPP) in plasma and cerebrospinal fluid (CSF) and rostral spread in the CSF after lumbar intrathecal, extradural and i.v. administration. Anaesthetized pigs were given a lumbar intrathecal, lumbar extradural or an i.v. injection of a mixture of [ 3 H]-labelled and unlabelled CPP. CSF was sampled over 10 h through intrathecal catheters positioned at the L1, T5 and C1 vertebral levels. Blood samples were obtained over the same period. Haemodynamic and arterial blood-gas variables and acidbase balance were monitored during the study. The area under the radioactivity concentration-time curves showed a gradient between cervical and lumbar CSF radioactivity of about 1:2500 after intrathecal administration and about 1:140 after extradural administration, indicating that only small fractions of lumbar administered CPP spread rostrally. About 2% of an extradurally administered dose was found in the CSF. The N-methyl-D-aspartate (NMDA) receptor is involved in central transmission and modulation of nociceptive information. Indeed the NMDA receptor plays a significant role in spinal neuronal plasticity, such as central sensitization, wind-up and hyperalgesia [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . Hence, interference with spinal NMDA receptors may offer alternative treatment options in different pain states. The competitive NMDA receptor antagonist 3-(2-carboxypiperazin-4-yl)propyl-l -phosphonic acid (CPP) is both highly potent and receptor-specific, acting at the NMDA recognition site of the NMDA receptor complex [12, 13] . CPP exhibited antinociceptive effects in behavioural studies in rat [14] and abolished central sensitization in electrophysiological experiments [10] . Spinal cord blood flow (SCBF) remained unchanged after intrathecal (i.t.) administration of CPP in rats [15, 16] , while chronic i.t. administration did not cause morphological changes in the spinal cord [17] . However, as NMDA receptors are both widely distributed in the central nervous system and involved in a large number of neuronal processes [18] , it may be difficult to produce an effective drug concentration near the target site, that is, the spinal cord, without affecting other NMDA receptorregulated neuronal processes in the brain. Although the drugs may be administered near the target organ by i.t. or extradural injection, rostral spread of the drug via the CSF may produce side effects by interference with supraspinal NMDA receptors [19] .
The N-methyl-D-aspartate (NMDA) receptor is involved in central transmission and modulation of nociceptive information. Indeed the NMDA receptor plays a significant role in spinal neuronal plasticity, such as central sensitization, wind-up and hyperalgesia [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . Hence, interference with spinal NMDA receptors may offer alternative treatment options in different pain states. The competitive NMDA receptor antagonist 3-(2-carboxypiperazin-4-yl)propyl-l -phosphonic acid (CPP) is both highly potent and receptor-specific, acting at the NMDA recognition site of the NMDA receptor complex [12, 13] . CPP exhibited antinociceptive effects in behavioural studies in rat [14] and abolished central sensitization in electrophysiological experiments [10] . Spinal cord blood flow (SCBF) remained unchanged after intrathecal (i.t.) administration of CPP in rats [15, 16] , while chronic i.t. administration did not cause morphological changes in the spinal cord [17] . However, as NMDA receptors are both widely distributed in the central nervous system and involved in a large number of neuronal processes [18] , it may be difficult to produce an effective drug concentration near the target site, that is, the spinal cord, without affecting other NMDA receptorregulated neuronal processes in the brain. Although the drugs may be administered near the target organ by i.t. or extradural injection, rostral spread of the drug via the CSF may produce side effects by interference with supraspinal NMDA receptors [19] .
The aim of this study was to examine rostral spread of CPP following i.t. and extradural administration at the lumbar level using an experimental model in pigs [20] . Passage over the blood-brain barrier after i.v. administration of CPP, plasma and CSF pharmacokinetics, haemodynamic changes and route of systemic elimination were also studied.
Materials and methods
Male pigs of the Swedish native breed, weighing 25-32 kg and 12-14 weeks old, were used. The investigation was approved by the Ethics Committee for animal studies of the University of Uppsala. After premedication with pentobarbitone 15 mg kg" 1 i.p. and atropine 0.5 mg i.p., anaesthesia was induced with pentobarbitone 10 mg kg" 1 i.v. and maintained with a continuous infusion of methomidate 7.5 mg kg" 1 h" 1 and pancuronium 0.2 mg kg" 1 h" 1 and inhalation of 70% nitrous oxide in oxygen. Before the surgical procedure the animals received fentanyl lOugkg" 1 and, preceding all surgical incisions, lignocaine 10 mg ml" 1 was injected locally into the skin and subcutaneous tissues. Tracheotomy was performed and the lungs were ventilated mechanically to normocapnia with a Servo ventilator 900 B (Siemens Elema, Solna, Sweden). Body temperature, measured in the pulmonary artery, was maintained at 38 +1 °C by means of a heating blanket and infrared light.
Arterial and double-lumen central venous catheters were inserted via the right common carotid artery and the right external jugular vein, respectively. A 7-French gauge pulmonary artery catheter equipped with a thermistor was introduced via the right external jugular vein into a main branch of the pulmonary artery. The urinary bladder was cannulated via a small suprapubic incision.
ARTERIAL BLOOD-GAS TENSIONS, ACID-BASE BALANCE AND HAEMODYNAMIC MONITORING
Haemodynamic variables, arterial blood-gas tensions and acid-base balance were measured in the two groups of pigs in which CPP was given either extradurally or i.t. Heart rate, systemic and pulmonary artery pressure (MAP and MPAP, respectively), central venous pressure (CVP) and pulmonary capillary wedge pressure (PCWP) were measured and recorded continuously (Siemens Sirecust 1281 and Siredoc 220, Siemens Medical Electronics Inc., Danvers, MA, USA). Cardiac output (CO) was measured by thermodilution using the thermistor in the pulmonary artery, and 10 ml of iced 5 % glucose solution was used as indicator. Arterial and venous blood samples were obtained every hour for measurement of arterial blood-gas tensions, mixed venous oxygen saturation (Sv 02 ) and arterial acid-base balance (ABL2 and OSM2, Radiometer, Copenhagen, Denmark).
SPINAL AND EXTRADURAL CATHETERS
In the animals given the test drug i.t., four i.t. catheters were inserted. Two catheters (one for injection and one for sampling) were placed with the tip at the LI level, whereas the two other i.t. catheters, used for CSF sampling, were placed with the tip at the T5 and Cl levels, respectively. In the animals given drugs extradurally, three i.t. catheters used for CSF sampling were introduced with the tip at the LI, T5 and Cl levels, respectively. In addition, an extradural catheter, used for administration of CPP, was placed with the tip at the same level as the tip of the lumbar i.t. catheter. In the animals where the drug was given i.v., only one i.t. catheter, used for CSF sampling, was placed with the tip at the Cl level.
SURGICAL PROCEDURES FOR PLACEMENT OF INTRATHECAL AND EXTRADURAL CATHETERS
The animals were placed in the prone position. Catheters used for drug injection or sampling of CSF at the lumbar level were introduced via the L5-S1 interspace after surgical incision and removal of the ligamentum flavum. To place a lumbar i.t. catheter, a plastic guide wire (1.05 mm, ViggoSpectramed, Swindon, Wilts., UK) was introduced into the i.t. space via a small hole made with a needle. A polyethylene catheter (1.25 mm od, ViggoSpectramed) was then threaded over the guide wire and advanced 10 cm in a cranial direction, leaving the tip of the catheter at about the LI level. Care was taken to avoid leakage of CSF around the catheter. In the animals given an extradural injection of CPP, a catheter was introduced into the extradural space and advanced cranially to the same level as the lumbar i.t. catheter.
Catheters used for CSF sampling at the midthoracic and cervical levels were introduced into the i.t. space via the atlanto-cervical membrane. A midline incision was made between the occipital protuberance and the first thoracic spine. The muscles were cleaved bluntly and the atlantooccipital membrane was exposed. Two plastic guide wires were introduced via a needle into the i.t. space and threaded with polyethylene catheters, one of which was advanced 1 cm and the other 15 cm caudally, thus leaving the catheter tips at about the Cl and T5 levels, respectively. The doses of unlabelled CPP were chosen to give pharmacological active concentrations of CPP, as estimated from previous animal studies [14] . A 10-h sampling period followed, during which the anaesthetized animals remained prone. At the end of this experiment, the five pigs given [ 3 H]CPP i.t. were used in a third experiment together with one former, untreated pig. These six pigs were given [ 3 H]CPP 50 uCi i.v., dissolved in 0.9% saline to a total volume of 5 ml, injected into the pulmonary artery. To flush the catheters, all i.t. and extradural injections were followed by injection of 0.9 % saline 0.5 ml., and the i.v. injections were followed by 0.9% saline 5 ml. The total injection time was 45 s. At the end of the experiment the animals were killed with an i.v. injection of KC1 20 mmol.
DRUGS AND EXPERIMENTAL PROCEDURE

SAMPLING AND ANALYSIS
In the two groups where CPP was given spinally, samples of CSF (0.2-0.4 ml) from the lumbar, thoracic and cervical levels, and blood samples (3 ml) were obtained at 0, 20, 40, 60, 120, 180, 240, 300, 360, 420, 480, 540 and 600 min, respectively, and in the pigs injected i.t., a lumbar CSF sample was also obtained 10 min after administration. After i.v. administration of CPP, blood and CSF samples were obtained at 0, 20, 30, 40, 50, 60, 90, 120, 180 and 240 min and in addition blood samples were obtained at 1, 2, 3, 5 and 10 min. All blood samples were of arterial blood. Urine was sampled every hour from two pigs in the extradural and four pigs in the i.t. groups.
To the CSF, urine (1 ml) and separated serum (1 ml) samples was added 10 ml of scintillation cocktail (OptiPhase II, Fission, Wallac, Turku, Finland) and the radioactivity of the samples determined by liquid scintillation spectrometry (LKB Wallac 1215 Rackbeta II Liquid Scintillation Counter, Turku, Finland).
STABILITY OF [ 3 H]CPP
To demonstrate that radioactivity was non-volatile, samples of serum, CSF and urine were divided into two aliquots. One of the samples was dried in an oven at 40 °C for 24 h, before adding scintillation cocktail. The radioactivities of the dried and nondried samples were compared to ascertain if degradation of 
CALCULATIONS
The serum radioactivity concentration-time curve after i.v. drug administration was analysed using a biexponential equation to determine the rate constants of the initial distribution phase (0-5 min) and the elimination phase (60-240 min) [21] :
where a and /? are the respective rate constants, calculated by the least-squares method. The associated early (Tj) and late (Tf) half-lives were given as 0.693/a and 0.693//?, respectively.
The area under the radioactivity concentrationtime curves (AUC) was calculated by the trapezoidal rule [21] , with the addition of the residual areas, estimated from the last radioactivity measurement divided by the elimination rate constant (/?).
The initial volume of distribution in plasma (Vd{) after i.v. drug administration was calculated from dose/C(0), whereas the late volume of distribution in plasma (Fd 2 ) was determined from dose/(AUC x /?). Clearance was given by dose/AUC.
The availability or fraction of a given extradural dose that entered the CSF, and the systemic availability of i.t. and extradural doses were calculated from [21] :
(AUC lu after extradural injection x dose given i.t.)
AUC lu after i.t. injection x extradural dose).
(AUC se (ed) x dose given i.v.)
C(t) = C 1 (0 Otherwise, a monoexponential equation was fitted to the radioactivity concentration-time curves, using samples from 180 to 600 min in the spinal and 60-240 min in the i.v. groups:
The i.t. dose was compensated for the sampled radioactivity. All measured radioactivities were corrected for quenching after describing a quench curve. Analysis of variance with repeated measurements was used when appropriate. Values are mean (SEM).
Results
The surgical preparation and insertion of spinal catheters caused i.t. bleeding in two animals, which were subsequently excluded. In one animal it was not possible to obtain samples from the lumbar i.t. catheter. However, the animal was used for i.v. injection of [ AUC ce /AUC lu was 0.00042 (0.00016). The rmax at the thoracic level was 100 (38) min, at which time the thoracic: lumbar CSF radioactivity ratio was 0.032 (0.019). The rmax in serum was 120 (19) min, at which time the serum: lumbar radioactivity ratio was 0.0002 (0.0001). Systemic availability of the i.t. dose (F sys (i.t.)) was about 60% during sampling when corrected for the sampled radioactivity. The sampling procedure removed 35 % of the given radioactivity, of which 12% derived from the lumbar sample 10 min after injection of the drug, and another 10% from the lumbar CSF sample at 20 min. Less than 2 % of the total given dose of radioactivity was removed by sampling later than 60 min after injection.
EXTRADURAL INJECTION (fig. 2, table 1)
After extradural administration in five pigs, [ 3 H]CPP appeared in the lumbar CSF samples with a rmax of 20 min, that is in the first sample after injection. A monoexponential equation applied to the samples obtained from 180 to 600 min revealed a T\ of 133 (23) min. The CSF ce :CSF lu radioactivity ratios at rmax 96 (16)min at the cervical level and AITC,*/ AUC |U were 0.017 (0.006) and 0.007 (0.003), respectively, whereas the CSF th :CSF lu radioactivity ratios at rmax at the thoracic level and AITC^/ALTC,,, were 0.012 (0.006) and 0.022 (0.009). The systemic absorption rate was higher than that after i.t. drug administration, with a rmax of 28 (5) min in serum after injection, and the serum :CSF, U radioactivity ratio at rmax in serum was about 0.015, whereas the serum :CSF, U AUC ratio was about 0.017 (0.006). At rmax at the cervical level the radioactivity in plasma was about six-fold higher than that found in CSF^. The availability to the lumbar CSF of the extradural dose of CPP was calculated as about 2%, whereas systemic availability was 92%.
i.v. INJECTION (fig. 3, table 2) The plasma radioactivity concentration-time curve after i.v. administration of [ 3 H]CPP in six pigs showed a biphasic pattern. The initial T\ was 5.1 (1.1) min, and the initial volume of distribution (Vd { ) was 3.7 (0.2) litre. The plasma elimination half-life was 81 (10) min and the late apparent volume of distribution (Vd 2 ) was 13.8 (2.2) litre, that is about the size of the extracellular volume. As five of these pigs had been used previously for i.t. 
ARTERIAL GASES, ACID-BASE BALANCE AND HAEMODYNAMICS
There was no statistically significant difference between the groups given CPP extradurally and i.t. in pH a , Pa CO2 , Pa 02 , base excess or mixed venous oxygen saturation (Sv 02 ). Pa O2 decreased by about 20 % and 5v O2 by about 10 % in both groups during the 10-h study period.
In both groups MAP, MPAP, PCWP and CO decreased gradually during the study (fig. 4) . PCWP was slightly lower during the study in the extradural group than in the i.t. group, although this difference was also present at baseline, that is before drug injection. The group given CPP i.v. was not considered, as the conditions were different from the spinal group and the dose of CPP was considered too low to produce pharmacological effects. (table 3) . In one animal, radioactivity in the cervical cord was about 18 times lower than in the lumbar spinal cord, whereas no radioactivity was detected in the thoracic or cervical part of the cord in the other animal. No radioactivity was detected in the brain. The kidney contained approximately 20 times the radioactivity of the liver and about 40 times that of skeletal muscle. No radioactivity was detected in bile. Urine collected from two extradurally and four i.t. injected pigs revealed that about 65 % of the extradural and 50% of the i.t. radioactivity was excreted during the 10-h study period. 
Discussion
We have found that only small fractions of [ 3 H]CPP, administered i.t. or extradurally at the lumbar level, spread supraspinally. Rostral transport was timedependent and the concentration of radioactivity decreased with the distance from the site of injection. After lumbar intrathecal administration of [ 3 H]CPP, AUC ce /AUC lu and the gradient between cervical and lumbar CSF radioactivity was 1:2500 at the time when the cervical CSF radioactivity was highest. AUC C<; /AUC, U was 1:140 and the cervical: lumbar radioactivity gradient at rmax at the cervical level was about 1:60 after lumbar extradural injection. These large gradients suggest that it may be possible to obtain high concentrations in the spinal cord dorsal horn with only a small degree of rostral spread to supraspinal sites. Furthermore, i.t. administration may be safer than the extradural route in respect of supraspinal side effects.
We also found that Peak concentrations at Cl occurred at 2-3 h after i.t. injection and about 1-2 h after extradural administration. This is consistent with a study in mice where the concentration of another hydrophilic NMDA antagonist, cis-4-phosphonomethyl-2-piperidine carboxylic acid (CGS 19755) , peaked in the frontal cortex about 4 h after lumbar i.t. administration [23] . In humans, peak concentrations of morphine in CSF, sampled at the C7-T1 level after lumbar extradural administration, occurred about 3 h after extradural injection [24] . Morphine concentrations in cisterna magna after lumbar i.t. injection in sheep also peaked at 90-190 min [25] .
After i.v. administration of [ 3 H]CPP, the CSF: serum radioactivity gradient was 28% (range 18-35 %) . This is somewhat surprising in view of the pronounced hydrophilic properties of CPP [26] , as hydrophilic substances penetrate the blood-brain barrier poorly [27] . This suggests that, CPP may be effective when given systemically, although the supraspinal side effects would probably make this mode of administration difficult in clinical practice. Orally administered CPP was effective against experimental seizures in baboons [28] .
The distribution of drugs from the intrathecal space depends on the physiochemical properties of the drug. Lipophilic drugs readily enter the spinal cord where they are absorbed systemically, whereas hydrophilic drugs tend to remain in the CSF [23, 26, 29] . Many other factors influence the distribution of i.t. administered drugs [30] . However, the risk of rostral spread is greater with hydrophilic drugs, but such drugs may be useful in that their duration of action may be longer and they may be less prone to produce systemic side effects.
In the tissue samples obtained about 10-11 h after administration of [ 3 H]CPP, high levels of radioactivity were found in the kidneys, while liver tissue showed little radioactivity and none was found in bile ( [31] .
The calculated CSF availability of an extradural dose was about 2 %. This is about the same as that found after extradural morphine and pethidine in humans, where values of 2-4 % have been calculated [32, 33] .
Systemic availability after extradural [ 3 H]CPP was about 92%, whereas after i.t. administration it was only about 60 %. This low value may be acceptable when taking into account the inaccuracy associated with calculations based on low levels of radioactivity, as in the serum samples after i.t. administration. However, tissue radioactivity at the supraspinal level 10 h after extradural administration of [ From a pharmacokinetic point of view, the CSF cannot be regarded as a single compartment, as it is not well stirred, hence the calculated pharmacokinetic variables are true only for an arbitrary volume at the sampling site. Despite these reservations there was a striking homogeneity in the late half-lives within the CSF, irrespective of the route of administration or the level of sampling. This suggests that the major route of elimination from the CSF was penetration into and systemic absorption from the spinal cord, in addition to systemic absorption from the surrounding pia, arachnoid and dural microcirculation.
In this model, frequent sampling was performed, which may have interfered with the results obtained after both i.t. and extradural administration. The fraction of the injected drug sampled could be calculated in the pigs given i.t. [ 3 H]CPP. Less than 2 % of the drug was sampled after 60 min, and the pharmacokinetic variables calculated from CSF samples from 3 to 10 h were probably unaffected by this sampling. However, a total of 33 % of the i.t. administered [ 3 H]CPP was sampled during the first hour of the study, of which 12% and 10% was sampled at 10 and 20 min, respectively. The CSF curves obtained from all three spinal levels and their AUC values were probably reduced, although the relation between the AUC of the curves was probably not affected. The sampled fraction of the radioactivity available for the CSF in the extradural group was less than 35 % as no lumbar sample was taken at 10 min.
The total amount of CSF in a 25-kg pig is about 50 ml, with 10 ml in the spinal canal, as extrapolated from humans [34] . Although the total volume of CSF varies little because of the low compliance of the central nervous system, the production of CSF from the choroid arterial plexuses and reabsorption from the arachnoid villi may vary considerably depending on the osmotic and hydrostatic pressures in the CSF and blood, or on drug-induced effects [35] . The normal rate of CSF production may be about 0.13 ml min~', that is about 80 ml of CSF may be produced during the study, when estimated from humans [35] on the basis of body weight. Thus CSF turnover during the 10-h study may be estimated to be about 80 ml, of which 10-15 ml was sampled for analysis.
With the method used it was possible to monitor [ 3 H]CPP in CSF at the lumbar, thoracic and cervical levels and in serum for 10 h after either i.t., extradural or i.v. administration. However, the insertion of 3-4 i.t. catheters may have disturbed CSF bulk-flow. The prone position, immobilization, anaesthesia and mechanical ventilation throughout the study should also be taken into consideration when extrapolating the results to humans.
These results suggest that it may be possible to administer CPP spinally at the lumbar level in pharmacologically active doses without the risk of distribution of clinically significant amounts to the supraspinal level, and that the i.t. route of administration may be safer than extradural administration when considering the risk of supraspinal side effects.
